Skip to main content
Clinical Trials/ACTRN12615000032550
ACTRN12615000032550
Terminated
Phase 4

Implementation of HIV pre-exposure prophylaxis with antiretroviral medications amongst men at high risk for HIV infection; a demonstration project to evaluate feasibility, acceptability and adherence

Cairns and Hinterland Hospital and Health Service0 sites3,000 target enrollmentJanuary 19, 2015

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
HIV prevention
Sponsor
Cairns and Hinterland Hospital and Health Service
Enrollment
3000
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 19, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Men who have sex with men at risk of acquiring HIV due to high risk sexual practices. Willing and able to provide written informed consent. HIV negative at enrolment, medicare eligible, willing and able to partake in study procedures, fluent in English

Exclusion Criteria

  • HIV infected or signs or symptoms of acute HIV infection, creatinine clearance \<60ml/min, active clinically significant medical problems including active TB, poorly controlled cardiac disease, previous or currently diagnosed malignancy requiring further treatment. Hepatitis B surface antigen positive, current use of ART, including nucleoside analogues, non\-neucleoside reverse transcriptase inhibitors, protease inhibitors or investigational antiretroviral agents, interferon or interleukein therapy any investigational agents that may interact or affect PrEP medication and any nephrotoxic agents. Mental health issues, memory loss or other cognitive impairment or intellectual disability that may compromise participant safety and/or regimen adherence. Factors/conditions that may compromise a participant's retention in the study. Unwilling to adhere to any of the required study procedures

Outcomes

Primary Outcomes

Not specified

Similar Trials